Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria

Affiliations

Review

N J Wareham et al. BMJ. 2001.

. 2001 Apr 21;322(7292):986-8.

doi: 10.1136/bmj.322.7292.986.

¹ Department of Public Health and Primary Care, Institute of Public Health, University of Cambridge, Cambridge CB2 2SR, UK. njw1004@medschl.cam.ac.uk

No abstract available

Figures

Screening for type 2 diabetes. Undiagnosed diabetes must be detected.
Streets P. Streets P. BMJ. 2001 Aug 25;323(7310):453-4; author reply 454-5. BMJ. 2001. PMID: 11520852 Free PMC article. No abstract available.
Screening for type 2 diabetes. Screening would have important resource implications for primary care.
Walker M, Thomson A, Whincup PH. Walker M, et al. BMJ. 2001 Aug 25;323(7310):454-5. BMJ. 2001. PMID: 11548729 No abstract available.
Screening for type 2 diabetes. Population screening was not effective in former East Germany.
Berger M. Berger M. BMJ. 2001 Aug 25;323(7310):454; author reply 455. BMJ. 2001. PMID: 11548730 No abstract available.

1. Harris MI. Undiagnosed NIDDM: clinical and public health issues. Diabetes Care. 1993;16:642–652. - PubMed
1. Harris MI, Klein R, Wellborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 years before clinical diagnosis. Diabetes Care. 1992;15:815–819. - PubMed
1. UK Prospective Diabetes Study Group. UK prospective diabetes study 6. Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors. Diabetes Res. 1990;13:1–11. - PubMed
1. National Screening Committee. First report of the National Screening Committee. London: Health Departments of the United Kingdom; 1998. www.nsc.nhs.uk/pdfs/nsc_firstreport.pdf (accessed 14 January 2001).
1. Marks L. Counting the cost: the real impact of non-insulin-dependent diabetes. London: British Diabetic Association; 1996.